Minnesota Talc Mesothelioma Verdict: $10.2 Million Against J&J, Vi-Jon & Gold Bond for Asbestos in Body Powder
If you are reading this page, someone you love has probably been diagnosed with mesothelioma — or you have been diagnosed yourself — and you are searching for answers about talc powder. You may be sitting at a kitchen table at 2 a.m. with a pathology report in front of you, trying to understand how a body powder you used for decades could have caused a cancer that is almost always fatal. You may be angry, terrified, and exhausted all at once. We are going to tell you the truth about what just happened in a Minnesota courtroom, what the law says about your situation, and what you can still do about it. This page is legal information, not legal advice — but it is the kind of information most people never find until it is too late. The consultation is free. The call is 1-888-ATTY-911. We answer 24 hours a day, and we do not get paid unless we win your case.
In May 2026, a Minnesota state court jury returned a $10.2 million verdict in favor of a married couple who sued Vi-Jon LLC, Johnson & Johnson, Gold Bond, and other talc product manufacturers. The husband was 45 years old. The jury found that his mesothelioma — a rare, aggressive, and universally fatal cancer of the mesothelial lining — was caused by prolonged exposure to asbestos-contaminated talc in body powder products. His wife’s loss-of-consortium claim was part of the same verdict. The number reflects the gravity of a disease that carries a median survival of 12 to 21 months from diagnosis, even with aggressive multimodal treatment. It also reflects something this page will explain in detail: Minnesota is one of the few states where a jury can compensate the full human cost of a catastrophic injury with no statutory ceiling on non-economic damages. If you or someone in your family has been diagnosed with mesothelioma and has a history of using talc-based body powder products, the information on this page is for you. We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm that handles toxic tort and product liability cases and we take cases in Minnesota working with local counsel where required.
What This Verdict Means: A Minnesota Jury Accepted That Cosmetic Talc Caused Mesothelioma
The single most important fact about this verdict is not the dollar amount. It is the causation finding. A Minnesota jury — twelve people drawn from the Twin Cities metro, one of the most educated and diversely employed jury pools in the Upper Midwest — accepted the scientific link between cosmetic talc application and mesothelioma. That matters because the tobacco-asbestos-talc defense complex has spent years arguing that the kind of talc exposure you get from sprinkling body powder after a shower is too small, too diffuse, or too incidental to cause a disease that is usually associated with heavy industrial asbestos exposure. This jury rejected that argument. They heard the expert testimony, they saw the corporate documents, they examined the pathology, and they concluded that a 45-year-old man’s mesothelioma was caused by the powder products he used on his body.
That finding is significant for anyone in a similar situation for three reasons. First, it validates the scientific framework: asbestos-contaminated talc, applied cosmetically and inhaled over years, can serve as a causative agent for mesothelioma. Second, it demonstrates that a Minnesota jury — in a state with no damage caps — is willing to return a verdict in the eight figures for this kind of harm. Third, it sends a signal to the remaining defendants in the talc supply chain that the liability risk of taking these cases to trial is real and substantial. But a verdict is not the final step. Post-trial motions for judgment notwithstanding the law, motions for remittitur, and appeals can extend the timeline by months to years, and the final recovery amount may differ from the headline number. The article does not specify the breakdown of compensatory versus punitive damages, or the allocation between the husband’s injury claim and the wife’s loss-of-consortium claim. What we can say is that $10.2 million, in a no-cap state, for a 45-year-old mesothelioma patient, is a verdict that reflects the catastrophic nature of the harm.
The age of 45 is itself a critical fact. Mesothelioma typically presents in the sixth to seventh decade of life — most patients are diagnosed in their 60s or 70s, decades after their asbestos exposure began. A diagnosis at 45 is remarkably young, which suggests significant cumulative exposure and which supports a robust damages profile for lost earning capacity. At 45, this plaintiff faced what would otherwise have been 20 or more remaining working years. The loss of those years — the paychecks, the benefits, the retirement contributions, the household services, the companionship, the future — is what the jury was asked to value, and $10.2 million is their answer.
The Science: How Asbestos in Talc Powder Causes Mesothelioma
To understand why this verdict matters, you need to understand the disease and what causes it. Mesothelioma is a cancer of the mesothelium — the thin, protective lining that covers the lungs, the abdomen, and other internal organs. It is rare in the general population. It is also almost uniquely associated with one thing: asbestos exposure. The world’s leading cancer authority, the International Agency for Research on Cancer, classifies all forms of asbestos as a Group 1 known human carcinogen — the highest category, reserved for substances where the evidence of cancer-causing potential in humans is sufficient. Mesothelioma is so asbestos-specific that the disease itself is considered near-conclusive evidence of asbestos exposure. When a person develops mesothelioma, the disease points back to the exposure, even decades later.
Here is how the exposure works in a talc context. Talc is a mineral mined from the earth. Asbestos is also a mineral, and talc deposits are frequently found in close geological proximity to asbestos deposits — particularly tremolite and anthophyllite asbestos. When talc is mined, milled, and processed into cosmetic powder without rigorous asbestos testing and purification, the finished product can contain microscopic asbestos fibers. When a person applies that powder to their body — shaking it out, dusting it on, breathing the cloud that rises — those asbestos fibers are inhaled. The fibers are microscopic, durable, and biopersistent. Once they lodge in the pleura — the lining of the lungs — the body cannot clear them. They remain there for the rest of the person’s life, causing chronic inflammation, oxidative stress, and genotoxic damage to the mesothelial cells around them. Over decades, that chronic irritation drives malignant transformation. The disease process is slow, silent, and irreversible.
The latency period is the cruelest part. Mesothelioma typically appears 20 to 50 years after the first asbestos exposure — most often 30 to 40 years. Approximately 96% of mesothelioma cases have a latency of at least 20 years. The mean pleural mesothelioma latency is roughly 40 years. This means a person who used talc-based body powder in their 20s and 30s may not develop mesothelioma until their 60s or 70s — or, as in this Minnesota case, their 40s if the cumulative exposure was significant enough to compress the latency window. The long latency is also why the statute of limitations question in these cases is so important — and so different from ordinary injury cases. You did not know you were injured when you were sprinkling powder on yourself in 1985. You learned it the day the pathologist called with the biopsy results.
The defense will argue that your mesothelioma came from somewhere else — occupational asbestos exposure at a factory, a shipyard, a construction site, or from secondhand exposure through a family member’s work clothes. That is the “alternative exposure” defense, and it is the single most common tactic in talc mesothelioma litigation. The counter is twofold. First, mesothelioma is a signature disease — the tumor type, the location, and the fiber analysis can all point back to the specific exposure pathway. Second, a detailed occupational and residential history, combined with electron microscopy of the tissue itself, can identify the type and shape of the asbestos fibers embedded in the pleura. Different asbestos fiber types are associated with different exposure sources. The fibers tell a story, and that story can be read under a microscope — sometimes decades after the exposure occurred.
That is the single most important thing to understand about the evidence in a talc mesothelioma case: the pathology slides from the biopsy that diagnosed your mesothelioma can be re-examined under electron microscopy, and if asbestos fibers are present, they are still there — embedded in the tissue — because the body never cleared them. The disease keeps its own evidence. A generalist attorney who does not know to request electron microscopic analysis of the tissue blocks may never discover this proof. This is one of many reasons why experience in toxic tort litigation matters in these cases.
The Defendants: Johnson & Johnson, Vi-Jon, Gold Bond, and the Corporate Shell Game
A talc mesothelioma case is rarely about one defendant. It is about a supply chain — the companies that mined the talc, processed it, formulated it into products, branded it, distributed it, and sold it to consumers. This Minnesota verdict named multiple defendants, and understanding who they are and how they are structured is essential to understanding where the accountability — and the recoverable assets — actually live.
Johnson & Johnson is the most prominent talc defendant in American litigation, and its corporate structure is deliberately layered. The parent company is Johnson & Johnson. The historical talc seller was Johnson & Johnson Consumer Inc. (JJCI). When the talc liability became existential, J&J executed a corporate maneuver called a “Texas two-step” — a divisive merger under Texas law that split the consumer entity into two: one holding the valuable assets, the other (LTL Management LLC) holding the talc liability. LTL Management then filed for Chapter 11 bankruptcy, attempting to channel all talc claims into a bankruptcy trust and away from jury trials. That first filing was dismissed. A second filing was also dismissed. A third attempt, under a renamed entity called Red River Talc LLC, was denied confirmation and dismissed on March 31, 2025, by the U.S. Bankruptcy Court for the Southern District of Texas — Judge Christopher Lopez found vote-solicitation irregularities and impermissible nonconsensual third-party releases. Three times J&J tried to wall these cases off inside a bankruptcy it created on purpose. Three times a court threw it out. The cases are back in the regular court system, and this Minnesota verdict is proof that the system works when it is allowed to function.
J&J also spun off its consumer health business into a separate publicly traded company called Kenvue Inc. — the entity behind Band-Aid, Tylenol, and Listerine. Kenvue and J&J have indemnity arrangements between them, but Kenvue is a separate company. The corporate restructuring means that identifying the correct legal entity to sue — the one that actually holds the liability, the one that holds the assets, the one that carries the insurance — requires careful corporate analysis. This is the shell game, and it is the first thing any experienced product liability attorney unpacks in a talc case.
The scale of the J&J talc litigation is staggering. As of June 2026, the federal multidistrict litigation — MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, pending in the U.S. District Court for the District of New Jersey before Judge Michael A. Shipp — had approximately 68,000 actions pending. That is not a typo. More than 68,000 individual plaintiffs have filed federal talc cases against J&J alone. Many more are in state court, as this Minnesota case was. The MDL consolidates pretrial proceedings — discovery, expert challenges, bellwether trials — but each plaintiff retains an individual case. Joining the MDL does not merge your case into one big pot; you keep your own claim.
Vi-Jon LLC is a named defendant in this Minnesota case — a manufacturer and distributor of talc-based body powder products. Vi-Jon is a private-label and contract manufacturer that produces personal care products, including body powders sold under various brand names. As a manufacturer in the talc supply chain, Vi-Jon faces the same strict product liability, negligence, and failure-to-warn theories as the larger defendants. The specific corporate structure of Vi-Jon — parent companies, subsidiaries, insurance arrangements — is something that would be confirmed through Secretary of State filings and discovery in any individual case. What matters for the reader is this: every company that put asbestos-contaminated talc into a product that reached consumers is a potential defendant, and a thorough case identifies all of them.
Gold Bond is a brand of body powder products manufactured by Chattem, which is a subsidiary of Sanofi. Gold Bond body powder historically contained talc, and the brand is a named defendant in this and other talc litigation. The corporate chain — Chattem as the operating company, Sanofi as the pharmaceutical parent — is another layer of the shell game. Each entity in the chain may carry different insurance coverage, different assets, and different degrees of legal exposure.
The key takeaway for the reader is this: a talc mesothelioma case is not about suing one company. It is about mapping the entire supply chain — from the mine to the shelf — and holding every entity that touched the contaminated product accountable. A generalist who files against only the most obvious defendant may leave recovery on the table that a toxic tort specialist would have identified. If you are considering a talc mesothelioma claim, the defendant identification process should be exhaustive, and it should begin the day you call a lawyer.
Minnesota Product Liability Law: Your Rights and the Rules That Govern
Minnesota’s legal framework for product liability cases is, in several critical respects, more favorable to injured plaintiffs than the law of many other states. Understanding these advantages — and their limits — is essential to evaluating your case.
No statutory caps on compensatory damages. Minnesota does not impose statutory caps on compensatory damages in product liability or toxic tort actions. This means a jury has full discretion to award non-economic damages — pain, suffering, emotional distress, loss of enjoyment of life, disfigurement — up to the amount the evidence supports. In many states, non-economic damages are capped at a few hundred thousand dollars, which can gut the value of a case where the harm is primarily human rather than economic. Minnesota’s no-cap regime is one of the reasons the $10.2 million verdict in this talc mesothelioma case was possible. The jury was not constrained by an artificial ceiling.
Modified comparative negligence with a 50% bar. Minnesota follows a modified comparative negligence standard. Your own share of fault reduces your recovery, but it does not bar it entirely unless your fault equals or exceeds 50%. In a talc mesothelioma case, the defense may argue that the plaintiff assumed the risk by continuing to use a product after warnings were public, or that they were contributorily negligent in some way. But the 50% bar means that even if the jury assigns some fault to the plaintiff, recovery is reduced — not eliminated — as long as the plaintiff’s fault stays below 50%. Every percentage point the defense tries to pin on the plaintiff is money, which is exactly why the defense works so hard on comparative fault. The honest answer for most talc mesothelioma plaintiffs is that comparative fault is a minimal factor — consumers had no way to know that body powder contained asbestos, because no one told them.
Minnesota applies a modified comparative negligence standard with a 50% bar, meaning a plaintiff is barred from recovery only if their fault equals or exceeds 50%. Minnesota recognizes strict product liability under Restatement (Second) of Torts § 402A principles as adopted through state common law, and does not impose statutory caps on compensatory damages in product liability or toxic tort actions.
Strict product liability under Restatement (Second) § 402A. Minnesota recognizes strict product liability under the principles of the Restatement (Second) of Torts § 402A, as adopted through state common law. Strict liability means the plaintiff does not need to prove the manufacturer was negligent — only that the product was defective and unreasonably dangerous, and that the defect caused the injury. In a talc mesothelioma case, the defect is the presence of asbestos in a cosmetic product. The theories include design defect (talc products were unreasonably dangerous because asbestos contamination is inherent in the mineral’s geological co-occurrence with asbestos, and safer alternatives — cornstarch-based formulations — were commercially feasible and available), manufacturing defect (specific batches contained asbestos fibers above safe thresholds), and failure to warn (the manufacturers knew or should have known of the asbestos contamination risk through internal testing and industry literature but failed to adequately warn consumers).
Statute of limitations — six years, with the discovery rule. Minnesota’s statute of limitations for personal injury is generally six years. For latent diseases like mesothelioma, the discovery rule typically applies — meaning the clock starts when the plaintiff discovered, or through reasonable diligence should have discovered, the injury and its cause. In practice, for most mesothelioma patients, that means the clock starts around the date of diagnosis — when the pathologist confirmed the disease and the patient first learned that their cancer was connected to asbestos exposure. This is critically important because the exposure itself may have occurred 30 or 40 years ago. Without the discovery rule, virtually every mesothelioma case would be time-barred before the patient even knew they were sick. But you should not assume the discovery rule automatically applies to your situation. Some states impose an outer deadline — a statute of repose — that can cut off a claim even before discovery. We confirm the current Minnesota rule and any repose statute at the time of your consultation, because these deadlines are the single most common reason a valid case dies before it is ever filed. The safest approach is to contact an attorney as soon as possible after diagnosis — not because you are out of time, but because the evidence-preservation clock is running even when the statute of limitations clock has not started.
Daubert-style expert standard. Minnesota courts apply a Daubert-style reliability standard for expert scientific testimony. This means the judge acts as a gatekeeper, evaluating whether the expert’s methodology is reliable, testable, peer-reviewed, and generally accepted. In talc mesothelioma litigation, the causation battle is the central fight — and it is fought at the Daubert gate. The defense will try to exclude the plaintiff’s experts on the grounds that the science linking cosmetic talc exposure to mesothelioma is unreliable. The plaintiff’s experts must be prepared to defend their methodology, their dose reconstruction, and their differential diagnosis with rigor. A Minnesota jury’s willingness to accept the talc-mesothelioma link — as this $10.2 million verdict demonstrates — means that qualified experts can and do survive Daubert challenges in Minnesota courts. But the expert selection and preparation process is not something a generalist can handle. It requires specialists in occupational and environmental medicine, pathology, industrial hygiene, and toxicology.
Punitive damages. Minnesota permits punitive damages upon a showing of deliberate disregard for the safety of others. In talc litigation, the predicate for punitive damages is the evidence that manufacturers knew — through their own internal testing, conducted over decades — that their talc products contained asbestos, and chose not to warn consumers, not to reformulate, and not to recall. The fraudulent concealment and conspiracy-to-suppress theories support punitive damages exposure where proven. The Minnesota verdict article does not specify whether punitive damages were awarded or in what amount; the $10.2 million may be entirely compensatory or may include a punitive component. What we can say is that Minnesota law does permit punitives in appropriate cases, and the corporate knowledge evidence in talc cases is often exactly the kind of evidence that supports a deliberate-disregard finding.
The Regulatory Gap: Why No One Tests Cosmetic Talc for Asbestos
One of the most surprising facts in a talc mesothelioma case — and one that juries consistently find powerful — is that the federal government never required cosmetic talc to be tested for asbestos. The regulatory framework leaves consumers exposed in ways that would be unthinkable for food, drugs, or workplace materials.
The FDA regulates cosmetic talc products under the Federal Food, Drug, and Cosmetic Act, but cosmetics do not require pre-market approval or mandatory asbestos testing — a regulatory gap central to failure-to-warn theories. The FDA has issued guidance and proposed rules regarding asbestos testing methodology in talc-containing cosmetics but has not implemented a mandatory testing and certification regime.
The FDA does not require pre-market approval for cosmetics. A company can formulate a body powder with talc, package it, ship it to stores, and sell it to millions of consumers without ever testing a single batch for asbestos contamination. There is no certification. There is no inspection. There is no requirement that the talc be sourced from a mine that is asbestos-free. The FDA has the authority to act after a problem is discovered — it can issue warnings, request recalls, and seize adulterated products — but it does not have a proactive testing regime for asbestos in cosmetic talc.
OSHA regulates occupational asbestos exposure under 29 CFR 1910.1001, setting a permissible exposure limit of 0.1 fibers per cubic centimeter of air as an eight-hour time-weighted average, with an excursion limit of 1.0 fiber per cubic centimeter averaged over any 30-minute period. But OSHA’s jurisdiction covers workplaces — factories, refineries, construction sites. The body powder on your bathroom counter is not a workplace. The consumer who sprinkles it on after a shower is not an OSHA-regulated employee. Cosmetic consumer talc falls entirely outside the OSHA framework, leaving the exposure pathway that matters most to ordinary consumers — inhalation of powder during personal care use — essentially unregulated at the federal level.
This regulatory gap is both a defense argument and a plaintiff’s weapon. The defense argues that the manufacturers complied with all existing regulations — they sold a product that was legal to sell, and the government never told them they had to test for asbestos. The plaintiff’s answer is that compliance with a regulatory gap is not the same as safety. A company that knows its product contains a known human carcinogen — and the internal corporate documents in talc litigation have shown that manufacturers did their own testing and found asbestos in their talc — has a duty to warn consumers regardless of whether the government has gotten around to requiring it. The absence of a federal mandate does not create a license to withhold knowledge. The failure to warn is not that they violated an FDA rule. The failure to warn is that they knew and said nothing.
This is the point where the corporate testing documents become the spine of the case. The public litigation record in talc cases has produced extensive evidence of decades of internal corporate asbestos-in-talc testing by major manufacturers — testing that detected asbestos in finished products and raw materials, testing that was never disclosed to consumers, testing that was discussed in internal communications that never made it onto a warning label. The regulatory gap did not prevent these companies from knowing. It just meant no one forced them to tell you what they knew.
The killer takeaway here is this: the defense will say “we complied with all regulations.” The answer is: there were no regulations to comply with. The FDA does not require a single test for asbestos in the powder you put on your baby. That is not a defense — it is an indictment of the system that was supposed to protect you, and it is the gap these cases were built to close.
What Your Case Is Worth: Damages in Talc Mesothelioma Litigation
A mesothelioma diagnosis is not just a medical event — it is a financial catastrophe. The damages in a talc mesothelioma case are built from several categories, and understanding each one is essential to evaluating what your case is worth. The $10.2 million Minnesota verdict provides a benchmark, but every case is unique, and the value of yours depends on the specific facts of your exposure, your diagnosis, your earning history, and your family’s losses.
Economic damages are the losses that can be calculated with receipts and records. They include past and future medical expenses, lost wages, and lost earning capacity. Mesothelioma treatment is extraordinarily expensive. The multimodal protocol — surgery (pleurectomy/decortication or extrapleural pneumonectomy), chemotherapy (typically pemetrexed plus cisplatin), radiation therapy, and increasingly immunotherapy (nivolumab combined with ipilimumab) — can cost $500,000 to over $1 million, depending on the treatment course, the number of surgeries, the length of hospitalization, and whether the patient participates in clinical trials. For a 45-year-old patient, the lost earning capacity is potentially the largest single economic category. At 45, assuming a normal retirement age of 65, there are 20 or more remaining working years. A forensic economist projects the lost earnings using worklife expectancy tables — the expected number of years a person of a given age, sex, and education will actually be in the labor force — derived from federal labor data. The projection includes not just wages but also fringe benefits. According to the Bureau of Labor Statistics Employer Costs for Employee Compensation data, benefits run approximately 30% of total compensation for private-industry workers — health insurance, retirement contributions, paid leave, employer-side payroll taxes. A complete lost-earnings calculation counts all of it, because the family lost all of it. The final figure is then reduced to present value — a lump-sum amount today that, invested at a reasonable rate, would replace the lost future income stream. The Supreme Court’s decision in Jones & Laughlin Steel Corp. v. Pfeifer (462 U.S. 523, 1983) governs the present-value methodology in federal cases, and Minnesota courts apply similar principles.
Non-economic damages are the human losses that no receipt can capture: pain, suffering, emotional distress, loss of enjoyment of life, disfigurement, and the loss of the future the person no longer gets to live. Minnesota’s no-cap regime means the jury has full discretion on these damages. In a mesothelioma case, the non-economic component is often the largest part of the verdict — because the harm is not just medical bills and lost paychecks. It is the knowledge that you are going to die from a disease that was caused by a product you trusted, and that the companies that made it knew the danger and did not tell you. It is the months of treatment that do not work. It is the spouse who becomes a full-time caregiver. It is the children who watch their parent disappear. No spreadsheet can price that. A Minnesota jury can.
Loss of consortium is the spouse’s separate claim for the destruction of the marital relationship — the loss of companionship, affection, intimacy, and household services. In this Minnesota case, the wife’s loss-of-consortium claim was part of the $10.2 million verdict. A strong consortium claim recognizes that mesothelioma does not just happen to the patient — it happens to the entire family.
Punitive damages may be available in Minnesota upon a showing of deliberate disregard for the safety of others. Where the corporate knowledge evidence shows that the manufacturer tested its talc, found asbestos, and chose not to warn consumers or reformulate the product, the predicate for punitive damages is present. The Ingham v. Johnson & Johnson verdict — a 2018 Missouri case involving 22 plaintiffs who claimed talc caused ovarian cancer — illustrates the scale that punitive damages can reach in talc litigation. The jury awarded $4.69 billion. The Missouri Court of Appeals reduced it to approximately $2.12 billion. The Missouri Supreme Court denied review. The U.S. Supreme Court denied certiorari on June 1, 2021. The reduced award of approximately $2.1 billion stands as final. That is a talc verdict that survived appeal — one of the largest civil awards in Missouri history. It is cited here as industry context, not as a prediction of what any individual case will produce. Past results depend on the facts of each case and do not guarantee future outcomes.
Case value range. Based on the forensic dossier prepared for this verdict and comparable talc mesothelioma verdicts nationally, the case value range for a talc mesothelioma case in Minnesota is approximately $7 million on the low end to $15 million or more on the high end. The $10.2 million verdict anchors the middle of this range. Post-trial motions for remittitur could reduce the award, while post-judgment interest and sustained liability findings on appeal could push the ultimate recovery higher. Comparable talc mesothelioma verdicts nationally have ranged from several million dollars to nine figures where punitive damages were included. Minnesota’s no-damage-cap regime supports the upper range if the verdict is sustained. Collectibility is strong given the deep-pocket defendant profile — Johnson & Johnson alone has substantial assets — though J&J’s corporate restructuring and bankruptcy-strategy litigation history introduces collection-complexity risk that should be monitored. These figures are not a guarantee. They are a framework for understanding what is at stake and what a jury in your state might do with your facts.
Tax treatment. Under 26 U.S.C. § 104(a)(2), compensatory damages received on account of personal physical injuries or physical sickness are generally excluded from gross income for federal tax purposes. Punitive damages and interest are generally taxable. This means the bulk of a mesothelioma recovery — the compensation for the injury, the medical bills, the lost earnings — is generally tax-free. The exceptions are punitive damages and any interest component, which is why the structure of a settlement or judgment matters. This is legal information, not tax advice — you should consult a tax advisor about the specific treatment of any recovery.
The Evidence That Proves a Talc Mesothelioma Case — and How Fast It Can Disappear
Every talc mesothelioma case lives or dies on evidence. Some of that evidence is permanent — embedded in the patient’s own tissue. Some of it is fragile — corporate documents that can be “lost” or product samples that degrade. And some of it is obtainable only through legal process — FOIA requests, discovery demands, and subpoenas. Understanding what exists, who holds it, and how fast it can disappear is the difference between a case that can be proven and one that cannot.
Pathology slides and tissue blocks. The single most durable piece of evidence in a talc mesothelioma case is the pathology from the biopsy that diagnosed the disease. The tissue blocks and slides should be maintained indefinitely — they are the gold standard for proving both the diagnosis and the exposure. Under electron microscopy, asbestos fibers can be identified in the tissue itself, and the fiber type (tremolite, anthophyllite, chrysotile) can help trace the exposure back to its source. These slides do not degrade on a short timeline. They outlive the patient. But they must be requested from the pathology lab — they are not automatically preserved forever, and a lab’s retention policy may eventually dispose of them. The first preservation step in any talc mesothelioma case is a written demand to the pathology department to retain all blocks, slides, and tissue samples.
Medical records. All diagnostic imaging (CT, PET, MRI), biopsy results, pathology reports, treatment records, chemotherapy logs, radiation plans, surgical operative reports, and physician notes establish the diagnosis, the cell type (epithelioid, sarcomatoid, or biphasic), the tumor location, the staging, and the treatment course. These records also establish the prognosis — which drives the damages calculation. Medical records are retained by healthcare providers on schedules that vary by state and facility, but they are generally available for years. They should be requested in full as early as possible.
Product use history. This is the evidence that links the disease to the specific defendant’s products. The plaintiff must establish which talc products they used, how often, for how long, and in what manner. This evidence comes from the plaintiff’s own memory, from family members who can corroborate (“My mother used Johnson’s Baby Powder every day after her bath from the time I was a child until she was diagnosed”), from photographs showing product containers in the home, from purchase records if they exist, and from the sheer commonality of the products — Johnson’s Baby Powder and Gold Bond were among the most widely used personal care products in America for decades. Product identification does not require a receipt. It requires a credible, consistent, and corroborated usage history. The sooner this history is documented — in writing, with specific brands, approximate dates, and frequency — the stronger it is. Memories fade. Witnesses pass away. The documentation should begin the day you call a lawyer.
Corporate internal testing documents. These are the documents that prove the manufacturers knew. The public litigation record in talc cases has already produced extensive evidence of internal corporate asbestos-in-talc testing — test results, internal communications, quality control reports, and meeting minutes spanning decades. In active cases, these documents are subject to litigation holds and discovery demands. In concluded matters, key exhibits have been captured in the appellate record. For new cases, the discovery process is how these documents are obtained — and the discovery process cannot begin until a lawsuit is filed. This is one of the reasons why filing sooner rather than later matters: the corporate document trail is richest when the litigation hold is in place.
Product samples. If the plaintiff still has containers of the talc products they used, those containers — and any remaining powder — can potentially be tested for asbestos contamination. This is powerful evidence because it directly links a specific product to the contaminant. But most people do not keep empty powder containers for 30 years. The absence of product samples is not fatal to a case — the corporate testing documents and the pathology evidence can carry the causation proof — but their presence is a gift. If you have any old talc product containers, do not discard them. Preserve them.
FDA correspondence and regulatory filings. These documents show regulatory awareness, manufacturer compliance posture, and the gaps in federal oversight. They are obtainable through FOIA requests, though processing timelines can be lengthy — sometimes months. They support the negligence-per-se and regulatory-gap arguments. They also show what the manufacturers told the FDA and what the FDA knew — or did not know — about asbestos in cosmetic talc.
Expert witness reports and trial transcripts. In concluded cases, the expert testimony on causation — the most contested element in talc litigation — has been preserved in the trial transcripts and the appellate record. These materials form a library of causation opinions that can inform new cases. Court reporter transcripts must be ordered post-verdict. Exhibits must be designated and preserved per court rules.
The evidence preservation clock in a talc mesothelioma case is different from a vehicle crash case. There is no tow yard, no black box, no dashcam footage. But there is a clock nonetheless — and it runs on the pathology retention policy, the corporate document destruction schedule, the witness memory degradation curve, and the statute of limitations. The day you call a lawyer is the day the preservation letters go out — to the pathology lab, to the product manufacturers, to any entity that holds records relevant to your exposure and your diagnosis. Before that day, the clock is running and no one is watching it.
The Defense Playbook: How Talc Manufacturers Fight These Cases
The talc defense bar is sophisticated, well-funded, and experienced — these cases have been litigated for years, and the defense has developed a predictable set of tactics. Knowing them in advance is the best protection against them.
Play 1: The Daubert challenge to general causation. The defense will file a motion to exclude the plaintiff’s causation experts, arguing that the science linking cosmetic talc exposure to mesothelioma is unreliable. The counter is that asbestos is a Group 1 known human carcinogen, that mesothelioma is signature for asbestos exposure, and that the methodology used by the plaintiff’s experts — differential diagnosis, exposure reconstruction, fiber analysis — is the same methodology accepted in courts across the country. This Minnesota jury’s acceptance of the talc-mesothelioma link is itself evidence that the science survives Daubert in this jurisdiction.
Play 2: The product identification challenge. The defense will argue that the plaintiff cannot prove they used this specific defendant’s product, or that they used it enough to cause the disease. The counter is the corroborated usage history — family testimony, commonality of the products, and the absence of any meaningful warning that would have alerted the consumer to the asbestos risk. The defense does not need to prove the plaintiff avoided the product; the plaintiff needs to prove they used it. Decades of daily use of a ubiquitous personal care product is not a difficult factual question for a jury.
Play 3: The alternative exposure defense. The defense will argue that the mesothelioma came from occupational asbestos exposure, secondhand exposure, or environmental exposure — anything other than the cosmetic talc. The counter is a detailed occupational, residential, and environmental exposure history that identifies and rules out alternative sources. Electron microscopy of the tissue can identify the fiber types, which may be consistent or inconsistent with specific exposure pathways. A qualified exposure expert can reconstruct the dose and compare it across sources. The defense’s alternative-exposure argument is only as strong as the evidence it can produce — and if the plaintiff has no significant occupational asbestos history, the argument collapses.
Play 4: The statute of limitations defense. The defense will argue that the plaintiff waited too long after diagnosis to file. The counter is the discovery rule — the clock starts when the plaintiff knew or should have known of the injury and its cause. For most mesothelioma patients, that is the date of diagnosis. But the defense may argue that the plaintiff should have known earlier — that public reports about talc and asbestos were available years before the diagnosis. This is why prompt filing after diagnosis matters. The longer you wait, the more ammunition you give the defense on the SOL argument.
Play 5: The bankruptcy maneuver. J&J has attempted three times to channel talc liability into a bankruptcy entity — LTL Management LLC, then LTL Management again, then Red River Talc LLC. All three attempts were dismissed by federal courts. The most recent dismissal, on March 31, 2025, was by Judge Christopher Lopez of the U.S. Bankruptcy Court for the Southern District of Texas, who found vote-solicitation irregularities and impermissible nonconsensual third-party releases. J&J has since pivoted to defending cases in the tort system — which is exactly where this Minnesota jury held them accountable. The bankruptcy maneuver is not a legal defense to the merits; it is a procedural strategy to delay and deflect. But families should know it exists, because it has been used to pause litigation for years at a time.
Play 6: The “FDA compliance” defense. The defense will argue that the manufacturers complied with all existing FDA regulations and that the FDA never required asbestos testing for cosmetic talc. The counter is that compliance with a regulatory gap is not safety, and that a manufacturer’s duty to warn is not limited to what the government requires — it extends to what the manufacturer knew. The internal corporate testing documents are the answer to this defense. They knew. They tested. They found asbestos. They said nothing.
Play 7: The damages contest. The defense will challenge the life expectancy calculation, the earning capacity projection, and the treatment cost estimates. The counter is a board-certified life-care planner who builds the cost stream year by year, a forensic economist who reduces it to present value using accepted methodology, and the medical records that document the actual treatment course and prognosis. In mesothelioma cases, the defense may also argue that the patient’s shortened life expectancy limits the future damages — which is true, but it is also the cruelest argument in the case. The answer is that a shorter life over higher annual cost still totals millions — and that the non-economic value of the years lost is not diminished by their brevity.
Play 8: The quick settlement offer. In some cases, a defendant may offer a settlement early — before the full extent of damages is known, before the corporate documents are produced, before the expert reports are exchanged. A quick offer is not always a fair offer. In talc litigation, an early offer may be designed to close the case before the plaintiff’s attorney has had time to build the full damages model and identify all the defendants in the supply chain. This is why having an attorney who understands the full value of a talc mesothelioma case — not just the medical bills, but the lifetime earning capacity, the consortium, the pain and suffering, and the punitive exposure — matters. An offer that looks generous to a grieving family may be a fraction of what the case is worth.
How a Talc Mesothelioma Case Is Built: From Diagnosis to Verdict
Here is how a talc mesothelioma case is actually built — the chronological walk from the day of diagnosis to the day of verdict.
Week one: the call. The family calls. We take the call 24 hours a day. The first conversation is free, confidential, and focused on two things: understanding the medical situation and beginning the evidence-preservation process. We ask about the diagnosis — when, where, what cell type, what treatment plan. We ask about product use history — what brands, how long, how often. We ask about occupational history — to identify and rule out alternative asbestos exposure sources. We ask about family — spouse, children, dependents — because the damages model includes their losses too.
Week one to two: the preservation letters. The same week we are retained, the preservation letters go out. A written demand goes to the pathology department: retain all blocks, slides, and tissue samples. A written demand goes to every identified product manufacturer: preserve all corporate documents relating to talc sourcing, asbestos testing, quality control, internal communications, regulatory correspondence, and consumer complaints. A written demand goes to any other entity that holds relevant records — healthcare providers, employers, the FDA (via FOIA). These letters create a legal obligation to preserve evidence. If the recipient destroys evidence after receiving the letter, the court may impose sanctions — including an adverse-inference instruction telling the jury they may assume the destroyed evidence was as bad as the plaintiff says.
Month one to three: the medical and exposure record. We gather the complete medical record — every scan, every biopsy, every pathology report, every treatment note. We obtain the pathology slides and have them reviewed by an independent mesothelioma pathologist. We begin the exposure reconstruction — a detailed, documented history of every talc product the plaintiff used, every job they held, every residence they lived in, and every potential asbestos exposure source. We identify and interview corroborating witnesses — family members, coworkers, friends who can confirm the product use history.
Month three to six: the expert team. We build the expert team. A mesothelioma pathologist to confirm the diagnosis and identify fiber types in the tissue. An occupational and environmental medicine physician to perform the differential diagnosis and opine on causation. An industrial hygienist to reconstruct the exposure dose from cosmetic talc use. A life-care planner to build the future-care cost stream. A forensic economist to project lost earning capacity and reduce it to present value. Every expert is selected for their credentials, their courtroom experience, and their ability to survive a Daubert challenge.
Month six to twelve: discovery and depositions. The lawsuit is filed. Discovery begins — written interrogatories, document requests, and depositions. The corporate documents come out — the internal testing results, the quality control reports, the internal communications about asbestos in talc. The corporate witnesses are deposed — the scientists who ran the tests, the executives who made the decisions, the regulatory affairs staff who communicated with the FDA. The defense experts are deposed — their methodology is examined, their assumptions are tested, their conclusions are challenged.
Year one to two: Daubert motions and trial preparation. The defense files Daubert motions to exclude the plaintiff’s experts. We respond with the full weight of the scientific literature — the IARC Group 1 classification, the peer-reviewed studies on asbestos in cosmetic talc, the epidemiological evidence on mesothelioma in cosmetic talc users. The court rules. The surviving experts prepare for trial. The exhibits are finalized. The witness outlines are written. The trial strategy is set.
Trial. The jury is selected. The evidence is presented. The pathologist shows the asbestos fibers in the tissue. The industrial hygienist reconstructs the dose. The corporate documents are displayed on the screen — the internal test results, the internal communications, the warnings that were never written. The defense argues alternative exposure, product identification, statute of limitations. The plaintiff argues strict liability, failure to warn, fraudulent concealment. The jury deliberates. The verdict is returned.
This is the path. It is long — typically two to three years from filing to verdict. But mesothelioma does not wait. That is why the case must be built while the patient is still able to participate — to tell their story, to identify the products they used, to describe the exposure that the defense will try to attribute to someone else.
Your First Steps After a Mesothelioma Diagnosis
If you or someone you love has been diagnosed with mesothelioma and has a history of using talc-based body powder products, here is what you should do — and what you should not do.
Do get the pathology confirmed. Mesothelioma is a complex diagnosis that requires expert pathology. If you have not already, get a second opinion from a mesothelioma specialist — an academic medical center or a National Cancer Institute-designated cancer center. The pathology confirmation is both a medical necessity and a legal foundation. The tissue blocks and slides from the biopsy are evidence. Make sure the pathology lab knows to retain them.
Do document your product use history. Write down — in as much detail as you can — every talc-based body powder product you or your loved one ever used. Brand names (Johnson’s Baby Powder, Gold Bond, Shower to Shower, store brands, any others). How often (daily, weekly, occasionally). How it was used (after bathing, on feet, on children, on the body). Who in the household used it. Where it was purchased. When the use began and ended. Do this now, while memories are fresh. Ask family members to do the same. This document is the foundation of the product identification evidence.
Do preserve any product containers. If there are any old talc powder containers in the home — in bathroom cabinets, in storage, anywhere — do not throw them away. Do not open them. Do not shake them. Place them in sealed plastic bags and store them safely. These containers, and any remaining powder inside, can be tested for asbestos contamination. They are physical evidence.
Do gather your medical records. Request copies of all diagnostic imaging, biopsy results, pathology reports, treatment records, and physician notes from every healthcare provider involved in the diagnosis and treatment. You have a legal right to your medical records. Keep organized copies.
Do document your work history. Write down every job you or your loved one ever held — the employer, the dates, the job duties, and any known exposure to asbestos or other hazardous materials. This is critical for ruling out occupational asbestos exposure as an alternative cause. The defense will look for any job that could have involved asbestos, and you need to be prepared to address it.
Do call a lawyer. This is not a case you can handle yourself. The causation science is complex. The corporate defendants are represented by national law firms with decades of experience in talc litigation. The expert testimony must survive a Daubert challenge. The discovery process is voluminous. The damages model requires a life-care planner and a forensic economist. And the statute of limitations clock is running. The consultation is free. The call is 1-888-ATTY-911. We answer 24 hours a day, 365 days a year — and when you call, you talk to a live person, not an answering service.
Do not give a recorded statement to anyone. If a representative of any talc product manufacturer, their insurance company, or their law firm contacts you — by phone, by letter, by email — do not give a statement. Do not sign anything. Do not agree to anything. These contacts are designed to limit the company’s liability, not to help you. Politely decline and call us.
Do not post about your case on social media. The defense will monitor social media accounts. Posts about your diagnosis, your treatment, your activities, your travel, your emotional state — all of it can be taken out of context and used to minimize your damages. If you have a mesothelioma case, assume someone is watching.
Do not wait. Mesothelioma is a disease with a short survival window. The patient’s ability to participate in the case — to tell their story, to identify products, to describe their exposure — is critical, and it may not last. The statute of limitations is running. The evidence is aging. The witnesses are aging. The day you call is the day the preservation letters go out. Every day before that is a day the clock is running and no one is watching it.
Frequently Asked Questions
Can talcum powder cause mesothelioma?
Yes — if the talc in the powder is contaminated with asbestos. Talc and asbestos are minerals that occur in close geological proximity, and talc mined from deposits that also contain asbestos can be contaminated with asbestos fibers. When asbestos-contaminated talc powder is applied to the body and inhaled, the asbestos fibers lodge in the lining of the lungs (the pleura) and, over a period of 20 to 50 years, can cause mesothelioma. This is not a theory — it is a causation finding that a Minnesota jury accepted in May 2026, returning a $10.2 million verdict against multiple talc product manufacturers. Asbestos is classified as a Group 1 known human carcinogen by the International Agency for Research on Cancer, and mesothelioma is essentially specific to asbestos exposure.
How long do I have to file a talc mesothelioma lawsuit in Minnesota?
Minnesota’s statute of limitations for personal injury is generally six years. For latent diseases like mesothelioma, the discovery rule typically applies — meaning the clock starts when you discovered, or through reasonable diligence should have discovered, your injury and its cause. For most mesothelioma patients, that means the clock starts around the date of diagnosis. If your loved one has already passed away, a wrongful death claim may have a different deadline. We confirm the current Minnesota rule and any applicable deadline at the time of your consultation, because statutes of limitations are the single most common reason a valid case is lost before it is filed. Do not assume you have plenty of time — call today.
What is the average settlement or verdict for a talc mesothelioma case?
There is no “average” because every case depends on its specific facts — the plaintiff’s age, earning history, family situation, treatment course, and the strength of the product identification and causation evidence. The Minnesota verdict in this case was $10.2 million. Comparable talc mesothelioma verdicts nationally have ranged from several million dollars to nine figures. The Ingham v. Johnson & Johnson verdict — a 2018 Missouri case involving ovarian cancer claims against talc — resulted in a jury award of $4.69 billion, which was reduced on appeal to approximately $2.12 billion and ultimately allowed to stand when the U.S. Supreme Court declined to review it in June 2021. That is a talc verdict that survived appeal. Past results depend on the facts of each case and do not guarantee future outcomes.
Can I sue if I used body powder products years ago?
Yes — if you have been diagnosed with mesothelioma and you have a history of using talc-based body powder products. The discovery rule means the statute of limitations typically starts at diagnosis, not at the time of exposure. Many talc mesothelioma plaintiffs used the products decades ago — in the 1970s, 1980s, 1990s, or later — and only learned of the connection when they were diagnosed. The long latency of mesothelioma (20 to 50 years) means that the exposure and the diagnosis are separated by decades, and the law accounts for this through the discovery rule.
What products contain asbestos-contaminated talc?
Talc-based body powder products — including baby powder, body powder, foot powder, and other cosmetic talc products — have been the subject of talc mesothelioma litigation. The defendants in this Minnesota case included Johnson & Johnson (manufacturer of Johnson’s Baby Powder), Vi-Jon LLC (manufacturer of talc-based body powder products), and Gold Bond (manufactured by Chattem, a subsidiary of Sanofi). Other talc product manufacturers have also been named in talc litigation. Not all talc products contain asbestos — but the geological reality is that talc deposits frequently co-occur with asbestos, and without rigorous testing and purification, contamination can occur. The FDA does not require mandatory asbestos testing for cosmetic talc, which means the consumer has no way to know whether a specific product is contaminated.
How is mesothelioma from talc different from occupational asbestos exposure?
Both involve asbestos fibers causing mesothelioma — the disease mechanism is the same. The difference is the exposure pathway. Occupational asbestos exposure typically involves heavy, sustained exposure in industrial settings — shipyards, construction sites, refineries, factories where asbestos was used as insulation or fireproofing. Cosmetic talc exposure involves lower-level but chronic exposure through personal care products — inhaling powder that contains asbestos fibers during daily use over years or decades. The defense in talc cases will argue that the mesothelioma must have come from occupational exposure, not from body powder. The counter is a detailed occupational history that rules out significant occupational asbestos exposure, combined with fiber analysis of the tissue that may identify fiber types consistent with cosmetic talc exposure. The Minnesota jury in this case accepted that cosmetic talc exposure can cause mesothelioma — that is the significance of the verdict.
Can my family sue if I die from mesothelioma?
Yes. If a mesothelioma patient dies, their family may pursue a wrongful death claim and/or a survival claim. A wrongful death claim compensates the surviving family members for their losses — lost financial support, lost companionship, lost guidance, funeral expenses. A survival claim preserves the damages the patient accumulated between the injury and death — the pain and suffering the patient experienced, the medical expenses incurred, the lost wages during the illness. The specific beneficiaries and the damages available depend on Minnesota’s wrongful death and survival statutes. If the patient is still alive when the case is filed, the case proceeds as a personal injury claim with a consortium claim for the spouse. If the patient passes away during the litigation, the case may be amended to include wrongful death claims. Our wrongful death practice page provides more information about these claims.
What if I used multiple talc products — can I sue all the manufacturers?
Yes. A talc mesothelioma case can name multiple defendants — every manufacturer whose product the plaintiff used and can identify. This Minnesota case named Vi-Jon LLC, Johnson & Johnson, Gold Bond, and other talc product manufacturers. The theory is that each defendant’s product contributed to the cumulative asbestos exposure that caused the mesothelioma. The plaintiff does not need to prove which specific product caused which specific fiber — they need to prove that the products they used contained asbestos and that the cumulative exposure from those products caused the disease. Identifying all the manufacturers in the supply chain — from the miners to the brand owners — is part of the case-building process.
Does Minnesota have damage caps for product liability cases?
No. Minnesota does not impose statutory caps on compensatory damages in product liability or toxic tort actions. This means a jury has full discretion to award non-economic damages — pain, suffering, emotional distress, loss of enjoyment of life — up to the amount the evidence supports. This is one of the reasons the $10.2 million verdict in this talc mesothelioma case was possible. In states with damage caps, the same verdict might have been reduced to a fraction of its value. Minnesota’s no-cap regime is a significant advantage for plaintiffs in catastrophic injury cases. Punitive damages may also be available in Minnesota upon a showing of deliberate disregard for the safety of others.
What evidence do I need for a talc mesothelioma lawsuit?
The core evidence in a talc mesothelioma case includes: (1) pathology slides and tissue blocks from the biopsy that diagnosed the mesothelioma — these can be analyzed under electron microscopy for asbestos fibers; (2) medical records documenting the diagnosis, cell type, treatment, and prognosis; (3) a documented product use history — which talc products were used, how often, for how long; (4) corroborating witness testimony from family members; (5) occupational and residential history to rule out alternative asbestos exposure; (6) corporate internal testing documents obtained through discovery — these show the manufacturers’ knowledge of asbestos in their talc; and (7) expert testimony on causation, exposure reconstruction, and damages. You do not need to have all of this evidence in hand when you call — that is our job to gather. But the sooner the preservation process begins, the stronger the evidence will be.
Is Johnson & Johnson still being sued for talc?
Yes. As of June 2026, approximately 68,000 talc cases were pending in the federal multidistrict litigation against J&J (MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, in the U.S. District Court for the District of New Jersey). Many additional cases are pending in state courts around the country — including this Minnesota case. J&J attempted three times to channel talc liability into a bankruptcy entity to avoid jury trials. All three attempts were dismissed by federal courts. The cases are back in the tort system, and juries are returning verdicts — like this $10.2 million Minnesota verdict.
What if I was partly at fault for using the products?
Minnesota follows a modified comparative negligence standard with a 50% bar. Your own share of fault reduces your recovery, but it does not bar it entirely unless your fault equals or exceeds 50%. In practice, comparative fault is rarely a significant factor in talc mesothelioma cases — consumers had no way to know that body powder contained asbestos, because no one warned them. The manufacturers who knew and said nothing are the ones at fault. But the defense will try to pin percentage points on the plaintiff, because every point is money. That is why having an attorney who can push back on the comparative fault argument matters.
Why Attorney911: The Trial Team That Knows This Fight
We are Attorney911 — The Manginello Law Firm, PLLC. We are Legal Emergency Lawyers. We take toxic tort and product liability cases in Minnesota, working with local counsel and pro hac vice admission where required. We do not claim an office in Minnesota. We do not invent credentials. What we bring is decades of trial experience, a former insurance-defense attorney who knows how the other side values and defends cases, and a commitment to building every case as if it is going to trial — because that is the only way to get the other side to take it seriously.
Ralph Manginello is our Managing Partner. He has been licensed since November 6, 1998 — 27+ years of trial practice. He is admitted to the U.S. District Court for the Southern District of Texas, including federal trial work. He was a journalist before he was a lawyer, which means he knows how to find a story in a stack of documents — and the corporate testing documents in a talc case are where the story lives. He is a member of the Texas Trial Lawyers Association and the Houston Bar Association. He leads the active $10 million hazing lawsuit against Pi Kappa Phi at the University of Houston — a case that is being fought right now. He does not back down from large defendants with deep pockets. Read more about Ralph here.
Lupe Peña is our Associate Attorney. He has been licensed since 2012. Before he joined this firm, he sat in the rooms where insurance companies and their defense lawyers decided how to deny, delay, and devalue injury claims — because he was one of those defense lawyers. He knows how the other side sets reserves, how they pick their IME doctors, how they use surveillance and social media, and how they engineer recorded statements to get you to say “I’m feeling okay” before the full extent of your injuries is known. Now he uses that knowledge for injured clients. He is fluent in Spanish — he conducts full client consultations in Spanish without an interpreter. If your family prays in Spanish, we speak your language. Read more about Lupe here.
Our fee is contingency. We charge 33.33% if the case settles before trial and 40% if the case goes to trial. We do not get paid unless we win your case. The consultation is free. The call is free. You pay nothing out of pocket to find out whether you have a case. If we are not the right fit for your situation, we will tell you — and we will help you find someone who is.
We are available 24/7. Call 1-888-ATTY-911 — that is 1-888-288-9911. You will talk to a live person, not an answering service. If you are calling at 2 a.m. from a hospital room, we answer. If you are calling from a kitchen table with a pathology report in front of you, we answer. If you are calling for a parent who cannot call for themselves, we answer.
Hablamos Español. Lupe Peña conducts full consultations in Spanish, without an interpreter. Your family deserves to understand every word of what is happening with your case — in the language you think in, the language you grieve in, the language you trust.
This page is legal information, not legal advice. Past results depend on the facts of each case and do not guarantee future outcomes. Every case is different. The information on this page is based on publicly reported facts about the Minnesota talc mesothelioma verdict, the verified legal framework of Minnesota product liability law, and the scientific and regulatory record of asbestos in cosmetic talc. Nothing on this page states or implies that Attorney911 represents the plaintiffs in the Minnesota case or has taken any action on that case. We are a resource — for the education, the governing law, the evidence clocks, the decision power, and the honest case evaluation. If you or someone you love has been diagnosed with mesothelioma and has a history of using talc-based body powder products, contact us today. The consultation is free. The call is 1-888-ATTY-911. We do not get paid unless we win your case.
Call now. 1-888-ATTY-911. 1-888-288-9911. 24 hours a day. 365 days a year. Hablamos Español. No fee unless we win.